Gene · 23186
Papers2,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advancements in CRISPR screens for the development of cancer immunotherapy strategies. | Mol Ther Oncolytics | 2023 | 37876793 | PubTator, text mining | PubMed |
| Zmym4 is required for early cranial gene expression and craniofacial cartilage formation. | Front Cell Dev Biol | 2023 | 37854072 | PubTator, text mining | PubMed |
| The Involvement of Neuroinflammation in the Onset and Progression of Parkinson's Disease. | Int J Mol Sci | 2023 | 37834030 | PubTator, text mining | PubMed |
| Persistent homology analysis of type 2 diabetes genome-wide association studies in protein-protein interaction networks. | Front Genet | 2023 | 37823029 | PubTator, text mining | PubMed |
| PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression. | Cancer Cell Int | 2023 | 37807067 | PubTator, text mining | PubMed |
| A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma-From m6A Modification to Blood Biomarkers. | Cells | 2023 | 37759495 | PubTator, text mining | PubMed |
| A computational framework for the inference of protein complex remodeling from whole-proteome measurements. | Nat Methods | 2023 | 37749212 | PubTator, text mining | PubMed |
| Mechanism of HBx carcinogenesis interaction with non-coding RNA in hepatocellular carcinoma. | Front Oncol | 2023 | 37746253 | PubTator, text mining | PubMed |
| YAP silencing by RB1 mutation is essential for small-cell lung cancer metastasis. | Nat Commun | 2023 | 37739954 | PubTator, text mining | PubMed |
| Combined Targeting of NAD Biosynthesis and the NAD-dependent Transcription Factor C-terminal Binding Protein as a Promising Novel Therapy for Pancreatic Cancer. | Cancer Res Commun | 2023 | 37707363 | PubTator, text mining | PubMed |
| A CRISPR-based rapid DNA repositioning strategy and the early intranuclear life of HSV-1. | Elife | 2023 | 37702383 | PubTator, text mining | PubMed |
| Targeting reversible post-translational modifications with PROTACs: a focus on enzymes modifying protein lysine and arginine residues. | J Enzyme Inhib Med Chem | 2023 | 37667522 | PubTator, text mining | PubMed |
| A review of the therapeutic potential of histone deacetylase inhibitors in rhabdomyosarcoma. | Front Oncol | 2023 | 37664028 | PubTator, text mining | PubMed |
| Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression. | Cancer Res Commun | 2023 | 37663929 | PubTator, text mining | PubMed |
| FUS-ERG induces late-onset azacitidine resistance in acute myeloid leukaemia cells. | Sci Rep | 2023 | 37660196 | PubTator, text mining | PubMed |
| NMR structure verifies the eponymous zinc finger domain of transcription factor ZNF750. | J Struct Biol X | 2023 | 37655311 | PubTator, text mining | PubMed |
| PROTAC chemical probes for histone deacetylase enzymes. | RSC Chem Biol | 2023 | 37654508 | PubTator, text mining | PubMed |
| Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma. | Leukemia | 2023 | 37648814 | PubTator, text mining | PubMed |
| Brain-Derived Neurotrophic Factor Dysregulation as an Essential Pathological Feature in Huntington's Disease: Mechanisms and Potential Therapeutics. | Biomedicines | 2023 | 37626771 | PubTator, text mining | PubMed |
| Demethylase-independent roles of LSD1 in regulating enhancers and cell fate transition. | Nat Commun | 2023 | 37607921 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23186/papers?page=8